Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2010: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2009: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Research Abstract |
We demonstrated that addition of recombinant prostasin to human adrenocortical cells increased secretion of aldosterone to the media in a dose dependent manner. We also showed that camostat mesilate, a potent serine-protease inhibitor, suppressed the progression of renal injury in aldosterone-induced renal injury model rats and in 5/6 nephrectomized renal failure model rats. Since camostat has been already clinically used as a medicine for pancreatitis and esophagitis in Japan, early clinical application of camostat for renal failure can be expected.
|